Literature DB >> 2051901

Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis.

T Nouchi1, Y Tanaka, T Tsukada, C Sato, F Marumo.   

Abstract

The appearance of alpha-smooth-muscle-actin (alpha-smA)-positive cells during hepatic fibrosis was studied immunohistochemically in rat and human livers. In the normal rat liver, alpha-smA was observed only in vascular smooth muscle cells. With the progression of fibrosis induced by CCl4 injection, alpha-smA-positive cells appeared in the perisinusoidal space and the fibrous septa, and ultimately surrounded regenerative nodules. An increase of desmin-positive cells was recognized in the fibrotic areas and the perisinusoidal area. In the human liver, alpha-smA-positive cells appeared in the fibrotic area, whereas no desmin-positive cells were observed, except in vascular walls of the central vein and the portal tract, alpha-smA is a good marker for the detection of myofibroblast-like cells, and the appearance of alpha-smA in liver mesenchymal cells seems closely related to the process of hepatic fibrosis in both rat and man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051901     DOI: 10.1111/j.1600-0676.1991.tb00499.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  42 in total

1.  S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3/SMAD3 pathway.

Authors:  Zhiqiang Gong; Huisheng Ye; Yu Huo; Lei Wang; Yanhong Huang; Min Huang; Xingxing Yuan
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Authors:  A Schmitt-Gräff; A Desmoulière; G Gabbiani
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.

Authors:  Seh-Hoon Oh; Marzena Swiderska-Syn; Mark L Jewell; Richard T Premont; Anna Mae Diehl
Journal:  J Hepatol       Date:  2018-05-23       Impact factor: 25.083

4.  Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver.

Authors:  H Enzan; H Himeno; S Iwamura; T Saibara; S Onishi; Y Yamamoto; H Hara
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis.

Authors:  H Enzan; H Himeno; S Iwamura; T Saibara; S Onishi; Y Yamamoto; E Miyazaki; H Hara
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 6.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

7.  Morphological identification of and collagen synthesis by periacinar fibroblastoid cells cultured from isolated rat pancreatic acini.

Authors:  Y Kato; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

8.  Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

Authors:  David Waltregny; Laurence De Leval; Wendy Glénisson; Siv Ly Tran; Brian J North; Akeila Bellahcène; Ulrich Weidle; Eric Verdin; Vincent Castronovo
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Alpha-smooth-muscle actin expression in normal and fibrotic human livers.

Authors:  K Yamaoka; T Nouchi; F Marumo; C Sato
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

10.  Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver.

Authors:  Julien Villeneuve; Fanny Pelluard-Nehme; Chantal Combe; Dominique Carles; Christine Chaponnier; Jean Ripoche; Charles Balabaud; Paulette Bioulac-Sage; Sébastien Lepreux
Journal:  Comp Hepatol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.